CD Formulation Launches Tailed Solutions for Increased Bioavailability Excipients

In a recent statement, the York-based CRO company CD Formulation announces the launch of tailored solutions for increased bioavailability excipients, which aims to tackle the issue of poor bioavailability, a long-lasting challenge in drug development.

Newly Updated: Alfa Chemistry Introduces Environmental Standards to Achieve Fast and Accurate Environmental Analysis

Famed as a supplier of varieties of analytical reagents, Alfa Chemistry never let its customers down and always put customers’ concerns and needs in the first place. Hence, the company recently introduces environmental standards, which is a step to further diversify its offering of chromatography standards and also in response to the increasing needs for environmental analysis.

Canopy Launches Out of Stealth With $13 Million to Help Oncology Practices Adopt a Proactive Care Delivery Model

Canopy Launches Out of Stealth With $13 Million to Help Oncology Practices Adopt a Proactive Care Delivery Model

Oncology Pharma Company Announces Launch of Equity Crowdfunding Campaign

SciTech Development LLC, an oncology pharmaceuticals company, is pleased to announce its equity crowdfunding campaign on StartEngine.

MicrobioSeq Releases Microbial Transcriptomics for Disease Research and Drug Development

MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable de novo sequencing, genotyping, microarray, and bioinformatics services. With years of experience in the pharmaceutical and life science sectors, CD Genomics has announced Microbial Transcriptomics solutions, which hold promise in uncovering novel ways to treat disease and improve human health.

Ultralow Input RNA-Seq Service Now Available by CD Genomics RNA Solutions Platform

RNA Solutions is a platform that offers services for the revolutionizing study of RNA, targeting both coding and non-coding RNAs of different physiological functions. The scientists at CD Genomics are ready to help detect various types of RNA via meticulous and integrative approaches. CD Genomics is proud to launch the ultralow input RNA-seq service using leading-edge Illumina sequencing techniques.

VisualDx Celebrates One Year of Project IMPACT at AAD

UCare Selects HealthSparq to Power Price Transparency for Individuals and Families

STEMart Introduces Acute Systemic Toxicity Testing Service for Medical Devices

STEMart launches Acute Systemic Toxicity testing for the medical device industry.

Amerigo Scientific Introduces the Launch of Polystreptavidin 350

Amerigo Scientific introduces Polystreptavidin 350 for applications in lateral flow, ELISA or CLIA.

CD BioSciences Introduces Genetic Polymorphism Services for GPCRs Study

CD BioSciences introduces a series of Genetic Polymorphism services for the study of GPCR polymorphisms.

Absci Develops Groundbreaking Machine Learning Models for In-Silico Antibody Design, Powered by NVIDIA

-Absci to present in-silico drug discovery technology at NVIDIA GTC -Breakthrough ML achievements highlight the viability of the computational lead optimization pipeline -Absci collaborates with NVIDIA on research to accelerate and scale in-silico drug discovery platform

Integrated DNA Technologies Adds MLL Munich Leukemia Laboratory to Align Program

Qlucore participates at Redeye Theme Digital Health

Qlucore, listed on Nasdaq First North, participates on Redeye Theme Digital Health Day. CEO, Carl-Johan Ivarsson, presents the company at 09:30 and participates in the panel afterwards.

CD ComputaBio Announces PD-L1 Targeting Service for Anticancer Drug Research

BOC Sciences Optimizes PROTAC Platform to Boost Related Research

BOC Sciences optimizes its PROTAC platform of protein degradation technology to boost PROTAC research and development.

VERICHEM INTRODUCES LIQUID STABLE REFERENCE MATERIALS FOR AMMONIA TESTING WITH EXTENDED STABILITIES

VERICHEM releases multi-level set of liquid stable and ready-to-use clinical reference materials for the calibration and calibration verification of Ammonia assays with extended shelf-life stability.

Creative Biogene Unveils Comprehensive Services of Bacterial Genome Editing

Creative Biogene unveils its comprehensive services of bacterial genome editing for worldwide pharmaceutical partners after the self-optimization of homologous recombination technology and the CRISPR/Cas9 platform.

Winterlight Labs and Alzheimer Center Amsterdam to decentralize patient assessments in preclinical Alzheimer’s disease research

The Translation team at Francis Crick Institute are working with Cresset Discovery to bring computational chemistry expertise to the Crick

Cambridge, UK – March 29th, 2022 – Cresset Discovery, provider of CADD expertise for drug discovery, is collaborating with the Translation team at The Francis Crick Institute as expert computational chemist in residence.